Biofrontera AG announced that it has established a subsidiary to continue the commercialization of Ameluz® in the United Kingdom. The newly founded Biofrontera UK Ltd. Is based in Cambridge, UK and headed by Ms. Pilar de la Huerta and Dr. Montserrat Foguet as Managing Directors. The company will take over the marketing activities for Ameluz® and the red-light lamp BF-RhodoLED® in Great Britain.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 EUR | -1.40% | -18.94% | -58.32% |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.32% | 11.65M | |
+37.78% | 723B | |
+32.82% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.64% | 244B | |
-4.13% | 208B | |
+10.63% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- B8FK Stock
- News Biofrontera AG
- Biofrontera AG Establishes UK Subsidiary to Strengthen Its Sales Activities in the Country